J1786 Imuglucerase injection
Also known as: imiglucerase, Cerezyme
Imiglucerase injection. A glucocerebrosidase enzyme for Gaucher disease treatment.
In Plain Language
enzyme replacement therapy; genetic storage disease treatment
Clinical Context
Used for non-neuronopathic Gaucher disease (Type 1) to reduce hepatosplenomegaly and hematologic dysfunction. Intravenous enzyme replacement therapy.
RVU Information
CPT J1786 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1786?
CPT J1786 (Imuglucerase injection) is a J Codes (Drugs) code. Imiglucerase injection. A glucocerebrosidase enzyme for Gaucher disease treatment.
How is J1786 administered?
CPT J1786 is administered by a healthcare provider, typically via injection or infusion. Used for non-neuronopathic Gaucher disease (Type 1) to reduce hepatosplenomegaly and hematologic dysfunction. Intravenous enzyme replacement therapy. It is used by Genetics, Hematology, Internal Medicine.
When is CPT J1786 used?
Used for non-neuronopathic Gaucher disease (Type 1) to reduce hepatosplenomegaly and hematologic dysfunction. Intravenous enzyme replacement therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.